Lund, Sweden - 12 October 2026 - Camurus (NASDAQ STO: CAMX) today announced that Health Canada has issued a Notice of Compliance (NOC) for Oczyesa ® XR, octreotide subcutaneous depot, for maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results